Linked Data API

Show Search Form

Search Results

1522764
registered interest false more like this
date less than 2022-10-17more like thismore than 2022-10-17
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the Voluntary scheme for branded medicines pricing and access, whether her Department has made an assessment of the potential merits of an exemption from payments for new active substances from that scheme. more like this
tabling member constituency Harlow more like this
tabling member printed
Robert Halfon remove filter
uin 64035 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-10-25more like thismore than 2022-10-25
answer text <p>The Voluntary Scheme for Branded Medicines Pricing and Access includes a 36 month exemption from payments for drugs containing a new active substance, starting once the marketing authorisation has been granted. Treatment of new active substances under a future voluntary scheme is subject to negotiation.</p> more like this
answering member constituency Newark more like this
answering member printed Robert Jenrick more like this
question first answered
remove filter
answering member
4320
label Biography information for Robert Jenrick more like this
tabling member
3985
label Biography information for Robert Halfon more like this